Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02648828 · ClinicalTrials.gov registry record
Understanding Physician Signout Risk Perception
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 132
- Enrollment target
NCT02648828 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 132 participants.
The verdict
NCT02648828 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the ability of physicians and a statistical index (the Rothman score) to predict clinical deterioration over the next 24 hours. Clinical deterioration is defined as concern in change in vital signs or patient status requiring a call to the rapid response team, cardiopulmonary arrest, or transfer to the ICU.
Interventions
- OTHER Clinical deterioration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02648828
The ClinicalTrials.gov registry entry for NCT02648828 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical deterioration is the first listed.
NCT02648828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02648828 about?
NCT02648828 is a clinical study titled "Understanding Physician Signout Risk Perception". The purpose of the study is to compare the ability of physicians and a statistical index (the Rothman score) to predict clinical deterioration over the next 24 hours. Clinical deterioration is defined as concern in change in vital signs or patient status requiring a call to the rapid response team, ...
What is the current status of trial NCT02648828?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2015-07. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02648828?
The interventions under investigation include: Clinical deterioration (OTHER).
Who is sponsoring clinical trial NCT02648828?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.